Genenta Science SPA (GNTA)
3.237
+0.07
(+2.12%)
USD |
NASDAQ |
Jun 14, 16:00
Genenta Science Total Assets (Quarterly): 24.70M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 24.70M |
| June 30, 2023 | 29.04M |
| June 30, 2023 | 29.04M |
| December 31, 2022 | 35.86M |
| June 30, 2022 | 39.98M |
| Date | Value |
|---|---|
| June 30, 2022 | 39.98M |
| December 31, 2021 | 45.32M |
| June 30, 2021 | 15.82M |
| June 30, 2021 | 15.82M |
| December 31, 2020 | 21.53M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
15.82M
Minimum
Jun 2021
45.32M
Maximum
Dec 2021
29.71M
Average
29.04M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Stevanato Group SPA | 2.390B |
| Lipocine Inc | 25.45M |
| Relmada Therapeutics Inc | 84.41M |
| FibroGen Inc | 365.87M |
| NovaBay Pharmaceuticals Inc | 5.357M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.117M |
| Shareholders Equity (Quarterly) | 22.59M |